- Home
- IBIO vs ASPS Comparison
IBIO vs ASPS Comparison
Compare IBIO & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- ASPS
- Stock Information
- Founded
- IBIO 2008
- ASPS 1999
- Country
- IBIO United States
- ASPS Luxembourg
- Employees
- IBIO N/A
- ASPS N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- IBIO Health Care
- ASPS Consumer Discretionary
- Exchange
- IBIO Nasdaq
- ASPS Nasdaq
- Market Cap
- IBIO 24.3M
- ASPS 24.1M
- IPO Year
- IBIO N/A
- ASPS N/A
- Fundamental
- Price
- IBIO $3.80
- ASPS $0.82
- Analyst Decision
- IBIO Strong Buy
- ASPS
- Analyst Count
- IBIO 3
- ASPS 0
- Target Price
- IBIO $4.87
- ASPS N/A
- AVG Volume (30 Days)
- IBIO 427.1K
- ASPS 131.6K
- Earning Date
- IBIO 05-12-2025
- ASPS 04-24-2025
- Dividend Yield
- IBIO N/A
- ASPS N/A
- EPS Growth
- IBIO N/A
- ASPS N/A
- EPS
- IBIO N/A
- ASPS N/A
- Revenue
- IBIO $375,000.00
- ASPS $150,354,000.00
- Revenue This Year
- IBIO $36.00
- ASPS $47.29
- Revenue Next Year
- IBIO $33.33
- ASPS N/A
- P/E Ratio
- IBIO N/A
- ASPS N/A
- Revenue Growth
- IBIO 650.00
- ASPS 3.65
- 52 Week Low
- IBIO $1.50
- ASPS $0.43
- 52 Week High
- IBIO $6.89
- ASPS $2.11
- Technical
- Relative Strength Index (RSI)
- IBIO 38.87
- ASPS 55.60
- Support Level
- IBIO $3.80
- ASPS $0.65
- Resistance Level
- IBIO $4.23
- ASPS $0.78
- Average True Range (ATR)
- IBIO 0.44
- ASPS 0.08
- MACD
- IBIO -0.15
- ASPS -0.00
- Stochastic Oscillator
- IBIO 6.21
- ASPS 57.77
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.